tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yaron Werber, 75 are a BUY (70.09%), 30 are a HOLD (28.04%), 2 are a SELL (1.87%).
Analyst Yaron Werber, currently employed at TD COWEN, carries an average stock price target met ratio of 60.05% that have a potential upside of 24.08% achieved within 322 days. Previously, Yaron Werber worked at COWEN.
Yaron Werber’s has documented 196 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASND, Ascendis Pharma AS at 14-Nov-2024.
Analyst best performing recommendations are on ARGX (ARGENX NV ADR).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 7/17/2023. The price target of $533 was fulfilled within 3 days with a profit of $48.57 (10.03%) receiving and performance score of 33.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$280
$14.14 (5.32%)
$235
9 days ago
(07-May-2025)
16/21 (76.19%)
$4.16 (1.51%)
430
Buy
$320
$54.14 (20.36%)
$324
14 days ago
(02-May-2025)
12/16 (75%)
$38.78 (13.79%)
75
Hold
$330
$64.14 (24.13%)
$303
1 months 7 days ago
(09-Apr-2025)
13/14 (92.86%)
$38.91 (13.37%)
730
Sell
$294
$28.14 (10.58%)
$275
2 months 11 days ago
(04-Mar-2025)
4/5 (80%)
$-18.19 (-5.83%)
89
Buy
$329
$63.14 (23.75%)
$310
3 months 6 days ago
(09-Feb-2025)
1/2 (50%)
$34.21 (11.60%)
54
What Year was the first public recommendation made by Yaron Werber?
